Additional Funds Given to State-Wide TBI Study

Recently, the Toral Family Foundation has given additional funds to the Delray Medical Center in order to help those that have recently sustained a TBI.

Davie, FL (I-Newswire) April 8, 2013 - Recently, the TFF (Toral Family Foundation) has granted additional funding in order to expand a TBI (Traumatic Brain Injury) research study that is currently being led by Latha Ganti Stead MD, MBA, MS, FACEP, the principal investigator and Toral Family Foundation Endowed Professor of Traumatic Brain Injury at the University of Florida, College of Medicine. The purpose of this research study is to measure the quality of life of those whom have sustained a moderate to severe TBI as well as their families. This study will also focus on tracking and measuring the overall results for persons that have recently been diagnosed with a moderate to severe TBI.

In addition, the project will consist of a resource facilitation coordinator that will have direct contact with each person that has been diagnosed with a moderate to severe TBI within the first 24 to 72 hours. This will help to connect those families whose members have sustained a TBI to national, state and local resources critical to funding as well as care.

Through research, education and access to resources, the nonprofit organization of the Toral Family Foundation will focus on collaborating with the health care community in order to improve the lives of those with brain and spinal cord injuries. Many are hoping that this study will help to collect outcome related data that can help improve medical care in the chronic phase of a TBI as well as provide faster and easier care for a greater quality of life. The Delray site is expecting the study to begin by the middle of April of this year.

Contact Information

Toral Family Foundation
Giselle Reid
13131 SW 19th St.
Phone : 855-867-2533

Published in:

Health & Fitness

Published On:

April 8, 2013

Print Release:

Print Release

If you have questions regarding information in this press release contact the company listed above. is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.

Related Releases

Doctor Appointment Online Booking
The availability of Online Doctor is now a common phenomenon among users through the site . This online platform not only provides Doctor Appointment Online but also provides Doctor Consultation. Both the users and the doctors

Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide
Renub Research has announced the addition of the "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide" report to its offering

Using The Best Advice To Get In Shape
If you want to improve your muscle quickly, you have to ramp in the weight you make use of in your resistance workout routines. It is because you will only develop muscles once you practical experience a level of level of resistance which is a new co

Supplement Website Claims to Debunk and Demystify the World of Health and Fitness Supplements
"Supplement Critique" offers unbiased, real-world testing of supplement claims for weight loss, fitness and male enhancement supplements.

ProDermagenix Beauty Products from a Company Dedicated to Excellence and Customer Satisfaction
Avail of affordable skin care options from Prodermagenix. There's no need to go under the knife for wrinkle and blemish-free skin. Product trials await site visitors.